Evaluation by an internal medicine physician before cataract surgery is crucial to identify and manage systemic conditions that could increase the risk of anesthetic, surgical, or postoperative complications. Here are the key details:
Assess cardiovascular and pulmonary risk to tolerate sedation/anesthesia.
Optimize chronic conditions (diabetes, hypertension, anticoagulation).
Detect uncontrolled infections or comorbidities that contraindicate surgery.
Coordinate with the ophthalmologist to customize the perioperative plan.
✔ Current medical conditions:
Diabetes (risk of postoperative macular edema if HbA1c >8%).
Uncontrolled hypertension (increased risk of choroidal hemorrhage).
COPD or sleep apnea (risk with deep sedation).
✔ Medications:
Anticoagulants (warfarin, OCPs): Discontinue or adjust dose?
Antiplatelet agents (aspirin, clopidogrel): Generally continued.
Insulin or hypoglycemic agents: Adjust fasting schedules.
Cardiopulmonary: Murmurs, arrhythmias, crackles (indicate ECG if symptoms are present).
Neurological: Evaluate tremors or involuntary movements (affecting surgical positioning).
Airway: Anticipate intubation difficulties (if general anesthesia is required).
Blood chemistry
Glucose, electrolytes (Na⁺, K⁺, Cl⁻), creatinine, BUN, total protein, albumin.
Increases the risk of postoperative diabetic macular edema.
Requires adjustment of hypoglycemic agents/insulin during preoperative fasting.
Can cause arrhythmias under sedation.
Affects the elimination of drugs used during/during anesthesia.
Hemoglobin (Hb), hematocrit (Hct), leukocytes, platelets.
Can delay surgery if symptoms are present (fatigue, tachycardia).
Risk of tissue hypoxia during sedation.
Suggests active infection (relative contraindication for elective surgery).
Increased risk of bleeding (relevant if peribulbar anesthesia is planned).
Total cholesterol, LDL, HDL, triglycerides.
Associated with increased cardiovascular risk during the perioperative period.
Patients on statins should continue them (they prevent ischemic events).
Risk of acute pancreatitis (contraindication for elective surgery).
Total/direct bilirubin, AST, ALT, alkaline phosphatase, albumin, INR.
Suggests active hepatitis or drug toxicity (e.g., statins, acetaminophen).
May alter anesthetic metabolism.
Indicates liver failure or vitamin K deficiency.
Increases risk of bleeding (requires preoperative correction).
Associated with malnutrition or chronic liver disease.
Increased risk of postoperative corneal edema.
TSH, free T4, T3 (in selected cases).
Risk of severe bradycardia under sedation.
Increased sensitivity to anesthetic drugs.
Risk of thyrotoxic crisis due to surgical stress.
Relative contraindication until hormones are normalized.
Especially in patients with diabetes or altered blood glucose levels. Diabetic patients or those with fasting glucose >126 mg/dL.
Average blood glucose over the past 2-3 months.
HbA1c >8%: Increases the risk of:
Postoperative diabetic macular edema.
Delayed corneal healing.
Ideal presurgical goal: HbA1c <7-8% (according to the ophthalmologist's criteria).
If the value is very high (>9%), surgery may be postponed until glycemic control is optimized.
Patients with high HbA1c require strict glucose monitoring on the day of surgery.
PT (Prothrombin time) and PTT (Partial thromboplastin time): Evaluate the extrinsic and intrinsic pathways of coagulation.
INR (International Normalized Ratio): Standard for anticoagulated patients.
INR >3.0: Increases risk of intraocular hemorrhage (especially with peribulbar anesthesia).
Management:
Surgery under topical anesthesia: Does not always require discontinuation of anticoagulants (low risk).
If peribulbar/retrobulbar anesthesia is used: Adjust dose or temporarily discontinue (depending on thromboembolic risk).
Elevated PT/PTT indicate risk of spontaneous bleeding.
Fluid and electrolyte balance is crucial for cardiac and neuromuscular function.
Increases the risk of arrhythmias under sedation.
Requires preoperative correction (K⁺ supplementation).
Can cause perioperative confusion or seizures.
Associated with parathyroid or metastatic disease.
Can alter muscle and cardiac contraction.
Very useful in severe COPD or suspected active infection. Also to rule out pathology in healthy patients
To rule out pathology in healthy patients and better assess patients with heart disease
❌ Acute infection (respiratory, urinary, etc.).
❌ Decompensation of chronic diseases:
HBP with BP >180/100 mmHg.
Hyperglycemic crisis (blood glucose >250 mg/dL).
❌ Severe anemia (Hb <8 g/dL).
❌ INR >3.0 in patients on warfarin (requires reversal with vitamin K).
❌ TSH >20 mIU/L with symptoms (myxedema).
Anticoagulants (warfarin):
Surgery under topical anesthesia: Not always discontinued (low risk of bleeding).
If peribulbar block is required: Discontinue 3-5 days prior (depending on thromboembolic risk).
Metformin: Discontinue 24-48 hours prior (risk of lactic acidosis with IV contrast).
Diuretics: Adjust dose to avoid intraoperative hypotension.
ASA (American Society of Anesthesiologists): Classifies the patient into grades I (healthy) to V (moribund).
ASA I-II: Low risk (ideal candidates for outpatient surgery).
ASA ≥III: Requires multidisciplinary management (e.g., cardiologist).
The internist should communicate:
✔ Patient stability for surgery.
✔ Specific recommendations (e.g., need for intraoperative glucose monitoring in diabetics).
✔ Allergies or adverse reactions to drugs.
It reduces cardiopulmonary complications associated with sedation by 30% (Journal of Perioperative Medicine).
Avoids last-minute cancellations due to hyperglycemia or uncontrolled hypertension.
Allows for choosing the safest type of anesthesia (topical vs. regional).
80% of postoperative complications in older patients are related to non-optimized comorbidities (OAA).
Unnecessary discontinuation of anticoagulants causes more thromboembolic events than bleeding (NEJM).
Diabetics with HbA1c >8% have a 3-fold increased risk of macular edema (Ophthalmology).